This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2003 Aug;48(8):1654-7.

doi: 10.1023/a:1024796630509.

Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies

Norio Akuta¹, Fumitaka Suzuki, Akihito Tsubota, Yoshiyuki Suzuki, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Yuzo Miyakawa, Hiromitsu Kumada

Affiliations

PMID: 12924664
DOI: 10.1023/a:1024796630509

Case Reports

Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies

Norio Akuta et al. Dig Dis Sci. 2003 Aug.

. 2003 Aug;48(8):1654-7.

doi: 10.1023/a:1024796630509.

Authors

Norio Akuta¹, Fumitaka Suzuki, Akihito Tsubota, Yoshiyuki Suzuki, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Yuzo Miyakawa, Hiromitsu Kumada

Affiliation

¹ Division of Gastroenterology, Toranomon Hospital, Tokyo, Japan.

PMID: 12924664
DOI: 10.1023/a:1024796630509

No abstract available

PubMed Disclaimer

Similar articles

Acute hepatitis C infection: an indication for alfa interferon therapy?
van der Vlies CH, Tang TJ, Niesters HG, Zondervan PE, Janssen HL, de Man RA. van der Vlies CH, et al. Neth J Med. 2000 Jul;57(1):30-3. doi: 10.1016/s0300-2977(00)00027-9. Neth J Med. 2000. PMID: 10863000 No abstract available.
A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H. Uyama H, et al. Hepatogastroenterology. 2003 Nov-Dec;50(54):2112-6. Hepatogastroenterology. 2003. PMID: 14696476 Clinical Trial.
[Treatment of hepatitis C virus infection].
Zeuzem S. Zeuzem S. Praxis (Bern 1994). 2005 May 4;94(18):721-6. doi: 10.1024/0369-8394.94.18.721. Praxis (Bern 1994). 2005. PMID: 15938383 Review. German.
Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
Tomimatsu M, Aizawa Y, Chuganji Y, Ishizuka H, Fujita Y, Aizawa R, Abe H, Matsuda T, Itou Y, Nakanishi H, Ushiyama H, Higuchi T, Fujimoto T, Endou H, Iga D, Ohta K, Kuroda H. Tomimatsu M, et al. J Gastroenterol Hepatol. 2006 Jul;21(7):1177-83. doi: 10.1111/j.1440-1746.2006.04311.x. J Gastroenterol Hepatol. 2006. PMID: 16824072
[Therapy of hepatitis C].
Moradpour D, Blum HE. Moradpour D, et al. Praxis (Bern 1994). 2002 May 29;91(22):977-82. doi: 10.1024/0369-8394.91.22.977. Praxis (Bern 1994). 2002. PMID: 12094432 Review. German.

See all similar articles

Cited by

Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.
Cunningham EB, Applegate TL, Lloyd AR, Dore GJ, Grebely J. Cunningham EB, et al. Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):218-30. doi: 10.1038/nrgastro.2015.36. Epub 2015 Mar 17. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25782091 Review.

References

1. Hepatology. 1992 Aug;16(2):293-9 - PubMed
1. Lancet. 1994 Feb 12;343(8894):388-90 - PubMed
1. N Engl J Med. 1992 Dec 31;327(27):1899-905 - PubMed
1. J Med Virol. 2001 Mar;63(3):228-36 - PubMed
1. J Med Virol. 1998 Apr;54(4):256-64 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.